Goodmans appeared as counsel to Pharmascience Inc. in an appeal before the Supreme Court of Canada relating to the prohibition on the patentability of methods of medical treatment.
The Goodmans IP Litigation team appearing for Pharmascience consisted of Andrew Brodkin, Sandon Shogilev and Daniel Cappe.
Pharmascience, headquartered in Montreal, Quebec, has been a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving both the Canadian and international markets. With product distribution in over 50 countries, they provide 1,300 skus to pharmaceutical wholesalers, hospitals, and pharmacists and its facilities produce more than 5 billion dosage units of medicines every year.
For more information and to view the webcast of the hearing, click here.